Año 2019 / Volumen 111 / Número 6
Original
Endoscopic ultrasound-guided fiducial placement in pancreatic tumors: safety and technical feasibility

425-430

DOI: 10.17235/reed.2019.5873/2018

Susana Tabernero, Susana Prados, María del Carmen Rubio, Felipe de la Morena, Mercedes López, Emilio Sánchez,

Resumen
Background and aims: stereotactic body radiation therapy (SBRT) for pancreatic malignancies requires the placement of fiducials to guide treatment delivery. The aim of this study was to assess the safety and feasibility of endoscopic ultrasound (EUS) guided fiducial placement using a 22-gauge needle, in patients with pancreatic cancer undergoing SBRT. Methods: this single-center retrospective study included 47 patients with biopsy-proven advanced pancreatic cancer who underwent EUS-guided fiducial placement between February 2014 and February 2018. Primary outcome measurements included technical success, fiducial migration rate and procedural complications. Results: all 47 patients received a sufficient number of fiducials and could therefore undergo a successful SBRT. The mean number of fiducials inserted per case was 2 ± 1 (range 1-3) and no fiducial migration was noted. The adverse event rate was 4.2%, as one patient developed mild pancreatitis and another patient required one week of hospitalization one month after fiducial placement due to a duodenal abscess. Conclusions: EUS-guided fiducial placement is a safe and technically feasible procedure in centers with endosonographers that are well trained in EUS with FNA.
Share Button
Nuevo comentario
Comentarios

09/04/2020 1:54:52
???


Bibliografía
1. Buchler MW, Werner J, Weitz J. R0 in pancreatic cancer surgery: surgery, pathology, biology, or definition matters? Ann Surg. 2010;251(6):1011-2.
2. Badiyan SN, Molitoris JK, Chuong MD, et al. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings. Surg Oncol Clin N Am. 2017;26(3):431-53.
3. Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007;25(8):947-52.
4. Petrelli F, Comito T, Ghidini A, et al. Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials. Int J Radiat Oncol Biol Phys. 2017;97(2):313-22.
5. Kothary N, Heit JJ, Louie JD, et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol. 2009;20(2):235-9.
6. Pishvaian AC, Collins B, Gagnon G, et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc. 2006;64(3):412-7.
7. Park WG, Yan BM, Schellenberg D, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc. 2010;71(3):513-8.
8. Sanders MK, Moser AJ, Khalid A, et al. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc. 2010;71(7):1178-84.
9. DiMaio CJ, Nagula S, Goodman KA, et al. EUS-guided fiducial placement for image-guided radiation therapy in GI malignancies by using a 22-gauge needle (with videos). Gastrointest Endosc. 2010;71(7):1204-10.
10. Ammar T, Cote GA, Creach KM, et al. Fiducial placement for stereotactic radiation by using EUS: feasibility when using a marker compatible with a standard 22-gauge needle. Gastrointest Endosc. 2010;71(3):630-3.
11. Varadarajulu S, Trevino JM, Shen S, et al. The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: a case series. Endoscopy. 2010;42(5):423-5.
12. Choi JH, Seo DW, Park DH, et al. Fiducial placement for stereotactic body radiation therapy under only endoscopic ultrasonography guidance in pancreatic and hepatic malignancy: practical feasibility and safety. Gut Liver. 2014;8(1):88-93.
13. Davila Fajardo R, Lekkerkerker SJ, van der Horst A, et al. EUS-guided fiducial markers placement with a 22-gauge needle for image-guided radiation therapy in pancreatic cancer. Gastrointest Endosc. 2014;79(5):851-5.
14. Khashab MA, Kim KJ, Tryggestad EJ, et al. Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy. Gastrointest Endosc. 2012;76(5):962-71.
15. Majumder S, Berzin TM, Mahadevan A, et al. Endoscopic ultrasound-guided pancreatic fiducial placement: how important is ideal fiducial geometry? Endoscopic ultrasound-guided oncologic therapy for pancreatic cancer. Pancreas. 2013;42(4):692-5.
Artículos relacionados

Imagen en Patología Digestiva

Colangiopatía post-COVID: hallazgos ultrasonográficos y de CPRE

DOI: 10.17235/reed.2022.9218/2022

Carta

Angiosarcoma de aorta diagnosticado mediante ecoendoscopia

DOI: 10.17235/reed.2022.8879/2022

Imagen en Patología Digestiva

Linfoma pancreático durante el embarazo

DOI: 10.17235/reed.2022.8811/2022

Imagen en Patología Digestiva

When needles are not enough, forceps delivers!

DOI: 10.17235/reed.2022.8697/2022

Carta

Mesotelioma decidual maligno, ¿hasta dónde llegamos con USE?

DOI: 10.17235/reed.2021.8352/2021

Imagen en Patología Digestiva

Intraductal papillary mucinous neoplasm of the biliary tract: a lesion of the bile duct lumen

DOI: 10.17235/reed.2019.6186/2019

Editorial

Safe surgery for cystic tumors of the pancreas

DOI: 10.17235/reed.2019.6042/2018

Carta

A veces las cosas son lo que parecen

DOI: 10.17235/reed.2019.5911/2018

Carta al Editor

EUS-guided ethanol ablation therapy for gastric stromal tumors

DOI: 10.17235/reed.2017.5361/2017

Carta al Editor

Neoplasia neuroendocrina rectal

DOI: 10.17235/reed.2017.4836/2017

Revisión

Endoscopic ampullectomy: a technical review

DOI: 10.17235/reed.2016.3867/2015

Caso Clínico

Pelvic inflammatory myofibroblastic tumor mimicking a rectal cancer

DOI: 10.17235/reed.2015.3777/2015

Instrucciones para citar
Tabernero S, Prados S, Rubio M, de la Morena F, López M, Sánchez E, et all. Endoscopic ultrasound-guided fiducial placement in pancreatic tumors: safety and technical feasibility. 5873/2018


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 694 veces.
Este artículo ha sido descargado 229 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 15/08/2018

Aceptado: 06/12/2018

Prepublicado: 13/05/2019

Publicado: 07/06/2019

Tiempo de revisión del artículo: 59 días

Tiempo de prepublicación: 271 días

Tiempo de edición del artículo: 296 días


Compartir
Este artículo ha sido valorado por 3 lectores .
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas